ZYBERNO SCORE →
Is it a great business? Is it getting better?
36.0/100
WEAK BUSINESS
Anika Therapeutics, Inc. (ANIK) scores 36/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated?
+
The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.
The 4 Core Categories (25 points each):
1. PROFITABILITY (25 pts)
Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent
2. FINANCIAL STRENGTH (25 pts)
Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe
3. CASH FLOW QUALITY (25 pts)
Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)
4. GROWTH & CONSISTENCY (25 pts)
Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good
Score Interpretation:
→ View full ANIK quality analysis & detailed breakdown
Critical Financial Health Indicators
Return on Equity (Profitability):CRITICAL (-9.0%)
Debt-to-Equity (Solvency Risk):GOOD (0.34x)
Operating Margin (Operational Efficiency):CRITICAL (-11.3%)
Return on Capital (Capital Efficiency):CRITICAL (-10.7%)
Zyberno's Verdict
Anika Therapeutics, Inc. (ANIK) stock report — Zyberno Score 36/100 (WEAK BUSINESS), Margin of Safety -100.0%, -14% expected annual return. Full financial analysis on Zyberno.
According to Zyberno's DCF model, Anika Therapeutics, Inc. (ANIK) trades at $21.57 against an estimated intrinsic value per share of $4.08 — a -100.0% Margin of Safety based on Owner Earnings of $1.75M TTM, projected at 24.1% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of -13.7% annually.
Over the trailing twelve months, ANIK generated $1.75M in Owner Earnings. Capital was deployed as follows: $8.69M returned via share buybacks, $5.43M invested in capital expenditures. Reinvestment rate: 22.9%. Owner Earnings have grown at 24.1% annually over the trailing five years using log-linear regression.